Gene therapy startup Passage Bio raises $110M Series B, its second raise in less than a year

Posted on September 4, 2019 — Jessica Jones Gupta

Philadelphia-based novel gene therapy startup Passage Bio says it closed a $110 million Series B round of funding, less than seven months after raising a $115.5 million Series A. The company‚Äôs latest round of funding was led by Access Biotechnology, with participation from existing investors OrbiMed, Frazier Healthcare Partners, Versant Ventures, Lily Asia Ventures, New…